Search research articles
Contact Us
Filters
Showing results (581-590 of 618) with videos related to
Page
of 62
Sort By:
ACS Infectious Diseases
|
May 8, 2024
Discovery of 1,3,4-Oxadiazole Derivatives as Broad-Spectrum Antiparasitic Agents
Alexandra Ioana Corfu, Nuno Santarem, Sara Luelmo, et al.
Nucleic Acids Research
|
December 3, 2025
FAVOR 2.0: A reengineered functional annotation of variants online resource for interpreting genomic variation
Hufeng Zhou, Vineet Verma, Xihao Li, et al.
Nature Genetics
|
June 10, 2020
CTCF is dispensable for immune cell transdifferentiation but facilitates an acute inflammatory response
Grégoire Stik, Enrique Vidal, Mercedes Barrero, et al.
The Journal of Rural Health : Official Journal of the American Rural Health Association and the National Rural Health Care Association
|
May 12, 2021
Telephone veteran peer coaching for mental health treatment engagement among rural veterans: The importance of secondary outcomes and qualitative data in a randomized controlled trial
Karen H Seal, Jeffrey M Pyne, Jennifer K Manuel, et al.
Journal of Medicinal Chemistry
|
May 26, 2026
First-in-Class Covalent Inhibitors of PFKFB3: Discovery and Characterization in PDAC Models
Alessandra Fiore, Antonio Scarano, Giulia Antonini, et al.
Chemmedchem
|
February 17, 2025
The European Federation for Medicinal Chemistry and Chemical Biology (EFMC) Best Practice Initiative: Hit to Lead
Jean Quancard, Anders Bach, Chiara Borsari, et al.
Risk Management and Healthcare Policy
|
January 22, 2025
Cost-Benefit Analysis of in vivo Reflectance Confocal Microscopy for Melanoma Diagnosis in a Real-World Clinical Setting
Giacomo Matteo Bruno, Sergio Di Matteo, Caterina Longo, et al.
Journal of Medicinal Chemistry
|
August 23, 2017
5-(4,6-Dimorpholino-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine (PQR309), a Potent, Brain-Penetrant, Orally Bioavailable, Pan-Class I PI3K/mTOR Inhibitor as Clinical Candidate in Oncology
Florent Beaufils, Natasa Cmiljanovic, Vladimir Cmiljanovic, et al.
Drug and Alcohol Dependence
|
February 23, 2025
α-PHP: Acute effects and pharmacokinetic in male and female mice, and clinical data on related intoxications
Marta Bassi, Elisa Roda, Micaela Tirri, et al.
Environment, Development and Sustainability
|
June 26, 2023
Governance in the implementation of the UN sustainable development goals in higher education: global trends
Walter Leal Filho, Ismaila Rimi Abubakar, Mark C Mifsud, et al.
Page
of 62
Search research articles
Search
Showing results (581-590 of 618) with videos related to
Sort By:
Page
of 62
ACS Infectious Diseases
|
May 8, 2024
Discovery of 1,3,4-Oxadiazole Derivatives as Broad-Spectrum Antiparasitic Agents
Alexandra Ioana Corfu, Nuno Santarem, Sara Luelmo, et al.
Nucleic Acids Research
|
December 3, 2025
FAVOR 2.0: A reengineered functional annotation of variants online resource for interpreting genomic variation
Hufeng Zhou, Vineet Verma, Xihao Li, et al.
Nature Genetics
|
June 10, 2020
CTCF is dispensable for immune cell transdifferentiation but facilitates an acute inflammatory response
Grégoire Stik, Enrique Vidal, Mercedes Barrero, et al.
The Journal of Rural Health : Official Journal of the American Rural Health Association and the National Rural Health Care Association
|
May 12, 2021
Telephone veteran peer coaching for mental health treatment engagement among rural veterans: The importance of secondary outcomes and qualitative data in a randomized controlled trial
Karen H Seal, Jeffrey M Pyne, Jennifer K Manuel, et al.
Journal of Medicinal Chemistry
|
May 26, 2026
First-in-Class Covalent Inhibitors of PFKFB3: Discovery and Characterization in PDAC Models
Alessandra Fiore, Antonio Scarano, Giulia Antonini, et al.
Chemmedchem
|
February 17, 2025
The European Federation for Medicinal Chemistry and Chemical Biology (EFMC) Best Practice Initiative: Hit to Lead
Jean Quancard, Anders Bach, Chiara Borsari, et al.
Risk Management and Healthcare Policy
|
January 22, 2025
Cost-Benefit Analysis of in vivo Reflectance Confocal Microscopy for Melanoma Diagnosis in a Real-World Clinical Setting
Giacomo Matteo Bruno, Sergio Di Matteo, Caterina Longo, et al.
Journal of Medicinal Chemistry
|
August 23, 2017
5-(4,6-Dimorpholino-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine (PQR309), a Potent, Brain-Penetrant, Orally Bioavailable, Pan-Class I PI3K/mTOR Inhibitor as Clinical Candidate in Oncology
Florent Beaufils, Natasa Cmiljanovic, Vladimir Cmiljanovic, et al.
Drug and Alcohol Dependence
|
February 23, 2025
α-PHP: Acute effects and pharmacokinetic in male and female mice, and clinical data on related intoxications
Marta Bassi, Elisa Roda, Micaela Tirri, et al.
Environment, Development and Sustainability
|
June 26, 2023
Governance in the implementation of the UN sustainable development goals in higher education: global trends
Walter Leal Filho, Ismaila Rimi Abubakar, Mark C Mifsud, et al.
Page
of 62